Clinical Trial Update: A Study of Xiangjurupining Capsule in the Treatment of Hyperplasia of Breast (Liver Stagnation and Phlegm Coagulation) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Xiangjurupining Capsule for breast hyperplasia has completed, sponsored by Tasly Pharmaceutical Group Co., Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Hyperplasia

Drugs mentioned

• Xiangjurupining Capsule

Snippet

Sponsor: Tasly Pharmaceutical Group Co., Ltd | Conditions: Hyperplasia of Breast | Phase 2 | Status: COMPLETED